Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
94.38 EUR | +1.99% | +0.53% | +9.18% |
05-29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
05-29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The company is one of the best yield companies with high dividend expectations.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- One of the major weak points of the company is its financial situation.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+9.18% | 160B | - | ||
+7.25% | 21.08B | A- | ||
+38.46% | 6.83B | B- | ||
+71.04% | 2.34B | - | C+ | |
-4.10% | 1.81B | - | ||
-1.60% | 1.75B | - | D+ | |
-29.63% | 1.16B | - | B+ | |
0.00% | 654M | - | - | |
+23.37% | 572M | C+ | ||
-22.33% | 417M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- PM Stock
- 4PM Stock
- Ratings Philip Morris International Inc.